8 Common Questions About Infusion Therapy — and Answers from RCCA’s Denis Fitzgerald, MD
If your physician has prescribed an infused medication for you, you’re in good company.
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
Black Americans with lung cancer are 18% less likely than white people to be diagnosed in the early stages of the disease, 23% less likely to receive surgery, and 21% less likely to survive 5 years after diagnosis, according to the American Lung Association.1
“One of the great medical and moral challenges of our time is to work so that all people benefit equally from the dramatic diagnostic and treatment advances that are being made against cancer,” says Denis Fitzgerald, MD, board chairperson of Regional Cancer Care Associates (RCCA), one of the nation’s largest networks of oncology specialists.
Dr. Fitzgerald, a board-certified medical oncologist and hematologist who practices with RCCA in Little Silver, NJ, adds, “While the need to eliminate disparities related to race or any other factor pertains to all forms of cancer, lung cancer warrants particular focus because it is the leading cause of cancer deaths in the United States. The American Cancer Society estimates that 130,180 Americans will die of lung cancer this year, including 14,160 Black Americans.”2,3
Iuliana Shapira, MD, RCCA’s chief medical officer, says, “Overcoming long-standing disparities in cancer care will require a concerted effort from all involved – clinicians and researchers, policy makers and payers, and, of course, patients, who can make a huge difference by being informed and proactive advocates for themselves and their health. The hopeful news with regard to lung cancer is that there are four significant steps people can take to reduce their risk for developing the disease and to increase the likelihood of early diagnosis and effective treatment.”
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
If your physician has prescribed an infused medication for you, you’re in good company.
Compassion, skill, collaboration, leadership, knowledge. These are just a few of the things that set some physicians apart from the rest, and they are qualities commonly found in those at the forefront of their field.
Offering patients the latest in cutting-edge treatments, including immunotherapies and targeted therapy, as well as access to a wide range of clinical trials, the Moorestown office of Regional Cancer Care Associates (RCCA) salutes the five members of its staff recently named to South Jersey Magazine’s list of Top Physicians for Women in 2022 – Hematology/Oncology.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.